Hologic, Inc. (HOLX) Reaches $38.89 Formed H&S; UBI SOFT ENTERTAINMENT SA ORDINARY SHARE (UBSFF) Shorts Raised By 21.93%

May 23, 2018 - By Ash

Hologic, Inc. (NASDAQ:HOLX) Logo

Hologic, Inc. (HOLX) formed H&S with $37.33 target or 4.00% below today’s $38.89 share price. Hologic, Inc. (HOLX) has $10.62 billion valuation. The stock decreased 0.46% or $0.18 during the last trading session, reaching $38.89. About 899,311 shares traded. Hologic, Inc. (NASDAQ:HOLX) has declined 11.91% since May 23, 2017 and is downtrending. It has underperformed by 23.46% the S&P500.

UBI SOFT ENTERTAINMENT SA ORDINARY SHARE (OTCMKTS:UBSFF) had an increase of 21.93% in short interest. UBSFF’s SI was 51,700 shares in May as released by FINRA. Its up 21.93% from 42,400 shares previously. With 500 avg volume, 103 days are for UBI SOFT ENTERTAINMENT SA ORDINARY SHARE (OTCMKTS:UBSFF)’s short sellers to cover UBSFF’s short positions. The SI to UBI SOFT ENTERTAINMENT SA ORDINARY SHARE’s float is 0.09%. It closed at $103 lastly. It is down 0.00% since May 23, 2017 and is . It has underperformed by 11.55% the S&P500.

Among 18 analysts covering Hologic (NASDAQ:HOLX), 12 have Buy rating, 0 Sell and 6 Hold. Therefore 67% are positive. Hologic has $5300 highest and $40 lowest target. $47.71’s average target is 22.68% above currents $38.89 stock price. Hologic had 63 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets with “Hold” on Friday, September 22. The stock of Hologic, Inc. (NASDAQ:HOLX) has “Buy” rating given on Thursday, February 8 by Piper Jaffray. Bank of America upgraded Hologic, Inc. (NASDAQ:HOLX) on Thursday, January 4 to “Buy” rating. Bank of America initiated Hologic, Inc. (NASDAQ:HOLX) on Friday, July 24 with “Buy” rating. The stock of Hologic, Inc. (NASDAQ:HOLX) earned “Underweight” rating by Barclays Capital on Thursday, July 30. The stock of Hologic, Inc. (NASDAQ:HOLX) has “Outperform” rating given on Monday, December 11 by Cowen & Co. The firm has “Buy” rating by Jefferies given on Friday, September 18. The company was downgraded on Thursday, May 3 by Leerink Swann. The rating was upgraded by Stifel Nicolaus on Friday, December 11 to “Buy”. The stock of Hologic, Inc. (NASDAQ:HOLX) has “Buy” rating given on Thursday, August 3 by Canaccord Genuity.

Investors sentiment decreased to 0.74 in Q4 2017. Its down 0.14, from 0.88 in 2017Q3. It turned negative, as 57 investors sold Hologic, Inc. shares while 165 reduced holdings. 70 funds opened positions while 94 raised stakes. 264.36 million shares or 0.45% less from 265.54 million shares in 2017Q3 were reported. Texas Permanent School Fund invested 0.04% in Hologic, Inc. (NASDAQ:HOLX). Asset Mgmt has invested 0.01% of its portfolio in Hologic, Inc. (NASDAQ:HOLX). Eagleclaw Cap Managment Limited Liability Com reported 0.86% stake. Ajo Limited Partnership holds 0.01% or 37,910 shares. Cambridge Inv Rech Advsr reported 0% stake. Goldman Sachs Gp holds 1.39 million shares or 0.01% of its portfolio. Marble Harbor Inv Counsel Ltd Limited Liability Company holds 0.08% in Hologic, Inc. (NASDAQ:HOLX) or 10,000 shares. New York-based Alliancebernstein Limited Partnership has invested 0.05% in Hologic, Inc. (NASDAQ:HOLX). Tiverton Asset Mgmt Ltd Liability Corp stated it has 0.01% of its portfolio in Hologic, Inc. (NASDAQ:HOLX). Wedge Cap L Limited Partnership Nc reported 1.09 million shares stake. Crestwood Advisors Gp Ltd Limited Liability Company holds 0% of its portfolio in Hologic, Inc. (NASDAQ:HOLX) for 32,504 shares. Guggenheim Capital Ltd owns 1.66 million shares. Rhumbline Advisers holds 0.05% or 560,096 shares. 15,596 were reported by Susquehanna Interest Group Incorporated Ltd Liability Partnership. Jane Street Ltd Liability Corporation has 0% invested in Hologic, Inc. (NASDAQ:HOLX) for 5,297 shares.

Analysts await Hologic, Inc. (NASDAQ:HOLX) to report earnings on August, 1. They expect $0.56 earnings per share, up 12.00% or $0.06 from last year’s $0.5 per share. HOLX’s profit will be $152.88 million for 17.36 P/E if the $0.56 EPS becomes a reality. After $0.53 actual earnings per share reported by Hologic, Inc. for the previous quarter, Wall Street now forecasts 5.66% EPS growth.

Since February 13, 2018, it had 3 buys, and 2 sales for $195,159 activity. 6,600 Hologic, Inc. (NASDAQ:HOLX) shares with value of $250,023 were bought by Nawana Namal. 13,000 Hologic, Inc. (NASDAQ:HOLX) shares with value of $504,400 were bought by Dockendorff Charles J. Shares for $199,826 were bought by Wendell Amy McBride. On Wednesday, May 2 Oberton Karleen Marie sold $487,840 worth of Hologic, Inc. (NASDAQ:HOLX) or 12,196 shares. Another trade for 7,000 shares valued at $271,250 was made by Bebo Allison P on Friday, March 16.

Ubisoft Entertainment SA engages in the production, publishing, and distribution of video games for consoles, PC, smartphones and tablets in physical and digital formats worldwide. The company has market cap of $11.00 billion. The firm creates and develops software, including scenarios, layouts, and game rules, as well as develops design tools and game engines. It has a 63.62 P/E ratio. It also develops in the area of online and mobile gaming; and distributes Ubisoft products, such as CD games, ancillary products, etc. to superstores and independent wholesalers.

Hologic, Inc. (NASDAQ:HOLX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>